Structural disruption of Ntox15 nuclease effector domains by immunity proteins protects against type VI secretion system intoxication in Bacteroidales

ABSTRACT Bacteroidales use type VI secretion systems (T6SS) to competitively colonize and persist in the colon. We identify a horizontally transferred T6SS with Ntox15 family nuclease effector (Tde1) that mediates interbacterial antagonism among Bacteroidales, including several derived from a single human donor. Expression of cognate (Tdi1) or orphan immunity proteins in acquired interbacterial defense systems protects against Tde1-dependent attack. We find that immunity protein interaction induces a large effector conformational change in Tde nucleases, disrupting the active site and altering the DNA-binding site. Crystallographic snapshots of isolated Tde1, the Tde1/Tdi1 complex, and homologs from Phocaeicola vulgatus (Tde2/Tdi2) illustrate a conserved mechanism of immunity inserting into the central core of Tde, splitting the nuclease fold into two subdomains. The Tde/Tdi interface and immunity mechanism are distinct from all other polymorphic toxin–immunity interactions of known structure. Bacteroidales abundance has been linked to inflammatory bowel disease activity in prior studies, and we demonstrate that Tde and T6SS structural genes are each enriched in fecal metagenomes from ulcerative colitis subjects. Genetically mobile Tde1-encoding T6SS in Bacteroidales mediate competitive growth and may be involved in inflammatory bowel disease. Broad immunity is conferred by Tdi1 homologs through a fold-disrupting mechanism unique among polymorphic effector–immunity pairs of known structure. IMPORTANCE Bacteroidales are related to inflammatory bowel disease severity and progression. We identify type VI secretion system (T6SS) nuclease effectors (Tde) which are enriched in ulcerative colitis and horizontally transferred on mobile genetic elements. Tde-encoding T6SSs mediate interbacterial competition. Orphan and cognate immunity proteins (Tdi) prevent intoxication by multiple Tde through a new mechanism among polymorphic toxin systems. Tdi inserts into the effector central core, splitting Ntox15 into two subdomains and disrupting the active site. This mechanism may allow for evolutionary diversification of the Tde/Tdi interface as observed in colicin nuclease–immunity interactions, promoting broad neutralization of Tde by orphan Tdi. Tde-dependent T6SS interbacterial antagonism may contribute to Bacteroidales diversity in the context of ulcerative colitis. Bacteroidales are related to inflammatory bowel disease severity and progression. We identify type VI secretion system (T6SS) nuclease effectors (Tde) which are enriched in ulcerative colitis and horizontally transferred on mobile genetic elements. Tde-encoding T6SSs mediate interbacterial competition. Orphan and cognate immunity proteins (Tdi) prevent intoxication by multiple Tde through a new mechanism among polymorphic toxin systems. Tdi inserts into the effector central core, splitting Ntox15 into two subdomains and disrupting the active site. This mechanism may allow for evolutionary diversification of the Tde/Tdi interface as observed in colicin nuclease–immunity interactions, promoting broad neutralization of Tde by orphan Tdi. Tde-dependent T6SS interbacterial antagonism may contribute to Bacteroidales diversity in the context of ulcerative colitis.

[1]  Y. Cheung,et al.  A glycine zipper motif governs translocation of type VI secretion toxic effectors across the cytoplasmic membrane of target cells , 2023, bioRxiv.

[2]  R. Lan,et al.  Bacteroides vulgatus attenuates experimental mice colitis through modulating gut microbiota and immune responses , 2022, Frontiers in Immunology.

[3]  R. F. de Souza,et al.  Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases , 2022, eLife.

[4]  Qiyun Zhu,et al.  Location-specific signatures of Crohn’s disease at a multi-omics scale , 2022, Microbiome.

[5]  L. Denson,et al.  Patient-Reported Outcomes Correlate With Microbial Community Composition Independent of Mucosal Inflammation in Pediatric Inflammatory Bowel Disease. , 2022, Inflammatory bowel diseases.

[6]  D. Jurėnas,et al.  Mounting, structure and autocleavage of a type VI secretion-associated Rhs polymorphic toxin , 2021, Nature Communications.

[7]  Brandon Yushan Feng,et al.  Benchmarking AlphaFold for protein complex modeling reveals accuracy determinants , 2021, bioRxiv.

[8]  J. Whitney,et al.  Structure of a bacterial Rhs effector exported by the type VI secretion system , 2021, bioRxiv.

[9]  S. Ovchinnikov,et al.  ColabFold: making protein folding accessible to all , 2022, Nature Methods.

[10]  Marek Basler,et al.  Type VI Secretion System and Its Effectors PdpC, PdpD, and OpiA Contribute to Francisella Virulence in Galleria mellonella Larvae , 2021, Infection and immunity.

[11]  L. Comstock,et al.  Mobile Type VI secretion system loci of the gut Bacteroidales display extensive intra-ecosystem transfer, multi-species spread and geographical clustering , 2021, bioRxiv.

[12]  A. Iwasaki,et al.  Commensal Microbiota Modulation of Natural Resistance to Virus Infection , 2020, Cell.

[13]  Paul A. Wiggins,et al.  An interbacterial DNA deaminase toxin directly mutagenizes surviving target populations , 2020, bioRxiv.

[14]  A. Filloux,et al.  Solving the Puzzle: Connecting a Heterologous Agrobacterium tumefaciens T6SS Effector to a Pseudomonas aeruginosa Spike Complex , 2020, Frontiers in Cellular and Infection Microbiology.

[15]  David R. Liu,et al.  A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing , 2020, Nature.

[16]  E. Pamer,et al.  Functional and Genomic Variation between Human-Derived Isolates of Lachnospiraceae Reveals Inter- and Intra-Species Diversity. , 2020, Cell host & microbe.

[17]  Luis Pedro Coelho,et al.  Statin therapy is associated with lower prevalence of gut microbiota dysbiosis , 2020, Nature.

[18]  Luis Pedro Coelho,et al.  Statin therapy is associated with lower prevalence of gut microbiota dysbiosis , 2020, Nature.

[19]  B. Rost,et al.  ProNA2020 predicts protein-DNA, protein-RNA and protein-protein binding proteins and residues from sequence. , 2020, Journal of molecular biology.

[20]  Jeff H. Chang,et al.  Effector loading onto the VgrG carrier activates type VI secretion system assembly , 2019, EMBO reports.

[21]  L. Hoffman,et al.  Human gut bacteria contain acquired interbacterial defence systems , 2019, Nature.

[22]  M. Laub,et al.  An interbacterial toxin inhibits target cell growth by synthesizing (p)ppApp , 2019, Nature.

[23]  P. Freemont,et al.  The Pseudomonas aeruginosa T6SS Delivers a Periplasmic Toxin that Disrupts Bacterial Cell Morphology , 2019, Cell reports.

[24]  L. Hoffman,et al.  Human gut bacteria harbor acquired interbacterial defense systems , 2019, Nature.

[25]  L. Journet,et al.  Structure and Activity of the Type VI Secretion System , 2019, Microbiology spectrum.

[26]  Kevin S. Bonham,et al.  Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.

[27]  M. Dunn,et al.  A human gut bacterial genome and culture collection for improved metagenomic analyses , 2019, Nature Biotechnology.

[28]  Paul A. Wiggins,et al.  Bifunctional Immunity Proteins Protect Bacteria against FtsZ-Targeting ADP-Ribosylating Toxins , 2018, Cell.

[29]  George Grant,et al.  Bacteroides thetaiotaomicron Ameliorates Colon Inflammation in Preclinical Models of Crohn’s Disease , 2018, Inflammatory bowel diseases.

[30]  Robert D. Finn,et al.  HMMER web server: 2018 update , 2018, Nucleic Acids Res..

[31]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[32]  Drew M. Pardoll,et al.  Patients with familial adenomatous polyposis harbor colonic biofilms containing tumorigenic bacteria , 2018, Science.

[33]  K. Orth,et al.  Type VI secretion system MIX‐effectors carry both antibacterial and anti‐eukaryotic activities , 2017, EMBO reports.

[34]  E. Borenstein,et al.  The Landscape of Type VI Secretion across Human Gut Microbiomes Reveals Its Role in Community Composition. , 2017, Cell host & microbe.

[35]  Zihao Pan,et al.  The Hcp proteins fused with diverse extended-toxin domains represent a novel pattern of antibacterial effectors in type VI secretion systems , 2017, Virulence.

[36]  P. Bork,et al.  Human gut microbes impact host serum metabolome and insulin sensitivity , 2016, Nature.

[37]  Young Ah Goo,et al.  Strain competition restricts colonization of an enteric pathogen and prevents colitis , 2016, EMBO reports.

[38]  Erh-Min Lai,et al.  VgrG C terminus confers the type VI effector transport specificity and is required for binding with PAAR and adaptor–effector complex , 2016, Proceedings of the National Academy of Sciences.

[39]  D. Goodlett,et al.  Human symbionts inject and neutralize antibacterial toxins to persist in the gut , 2016, Proceedings of the National Academy of Sciences.

[40]  N. Geva-Zatorsky,et al.  Bacteroides fragilis type VI secretion systems use novel effector and immunity proteins to antagonize human gut Bacteroidales species , 2016, Proceedings of the National Academy of Sciences.

[41]  L. Comstock,et al.  Type VI secretion systems of human gut Bacteroidales segregate into three genetic architectures, two of which are contained on mobile genetic elements , 2016, BMC Genomics.

[42]  A. Butte,et al.  The Integrative Human Microbiome Project: Dynamic Analysis of Microbiome-Host Omics Profiles during Periods of Human Health and Disease , 2014, Cell host & microbe.

[43]  Alain Filloux,et al.  Agrobacterium tumefaciens Deploys a Superfamily of Type VI Secretion DNase Effectors as Weapons for Interbacterial Competition In Planta , 2014, Cell host & microbe.

[44]  Laurie E. Comstock,et al.  Evidence of Extensive DNA Transfer between Bacteroidales Species within the Human Gut , 2014, mBio.

[45]  S. B. Peterson,et al.  Type VI secretion system effectors: poisons with a purpose , 2014, Nature Reviews Microbiology.

[46]  T. Gonen,et al.  Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates. , 2013, Molecular cell.

[47]  X. Su,et al.  Structure of the Type VI Effector-Immunity Complex (Tae4-Tai4) Provides Novel Insights into the Inhibition Mechanism of the Effector by Its Immunity Protein* , 2013, The Journal of Biological Chemistry.

[48]  Vivek Anantharaman,et al.  Polymorphic toxin systems: Comprehensive characterization of trafficking modes, processing, mechanisms of action, immunity and ecology using comparative genomics , 2012, Biology Direct.

[49]  Colin Kleanthous,et al.  Nuclease colicins and their immunity proteins , 2011, Quarterly Reviews of Biophysics.

[50]  Ning Ma,et al.  BLAST+: architecture and applications , 2009, BMC Bioinformatics.

[51]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[52]  C. Smith,et al.  Laboratory Maintenance and Cultivation of Bacteroides Species , 2008, Current protocols in microbiology.

[53]  K. Henrick,et al.  Inference of macromolecular assemblies from crystalline state. , 2007, Journal of molecular biology.

[54]  Colin Kleanthous,et al.  Colicin Biology , 2007, Microbiology and Molecular Biology Reviews.

[55]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[56]  Colin Kleanthous,et al.  Identification of the catalytic motif of the microbial ribosome inactivating cytotoxin colicin E3 , 2004, Protein science : a publication of the Protein Society.

[57]  C. Kleanthous,et al.  Immunity proteins: enzyme inhibitors that avoid the active site. , 2001, Trends in biochemical sciences.

[58]  A. Pommer,et al.  Specificity in protein-protein interactions: the structural basis for dual recognition in endonuclease colicin-immunity protein complexes. , 2000, Journal of molecular biology.

[59]  Liisa Holm,et al.  Using Dali for Protein Structure Comparison. , 2020, Methods in molecular biology.

[60]  M. Riley,et al.  Molecular mechanisms of bacteriocin evolution. , 1998, Annual review of genetics.